Mingyuan Li
Impact in
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
- Pharmaceutical Science top 5%
- Advanced Drug Delivery Systems
Papers in
-
- Antimicrobial Peptides and Activities 6
- Journals
- European Journal of Medicinal Chemistry (5 papers)Biochemical and Biophysical Research Communications (3 papers)International Journal of Food Science & Technology (2 papers)Cancer Biotherapy and Radiopharmaceuticals (2 papers)Archives of Virology (2 papers)
- Partner nations
- ChinaUnited StatesFrance
In The Last Decade
Mingyuan Li
86 papers receiving 1.7k citations
Hit Papers
Peers
Comparison fields: 5 of 125
- Biomaterials 277
- Pharmaceutical Science 127
- Microbiology 103
- Immunology 343
- Molecular Biology 828
Countries citing papers authored by Mingyuan Li
This map shows the geographic impact of Mingyuan Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mingyuan Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mingyuan Li more than expected).
Fields of papers citing papers by Mingyuan Li
This network shows the impact of papers produced by Mingyuan Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mingyuan Li. The network helps show where Mingyuan Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Mingyuan Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 4 | |
| 4 | 2025 | 0 | |
| 5 | 2024 | 0 | |
| 6 | 2024 | 0 | |
| 7 | 2023 | 25 | |
| 8 | 2022 | 5 | |
| 9 | 2022 | 2 | |
| 10 | 2022 | 8 | |
| 11 | 2022 | 12 | |
| 12 | 2020 | 108 | |
| 13 | 2019 | 27 | |
| 14 | 2016 | 2 | |
| 15 | A study of high cell density cultivation process of recombinant Helicobacter pylori multi-epitope vaccine engineering bacteria. | 2015 | 4 |
| 16 | 2014 | 12 | |
| 17 | The Development of Compound Microorganism Bacterium Agent Using in the Production of Pixian Bean Paste | 2012 | 1 |
| 18 | 2012 | 2 | |
| 19 | 2012 | 5 | |
| 20 | 2009 | 82 |
About Mingyuan Li
Mingyuan Li is a scholar working on Computational Mathematics, Microbiology, Biotechnology, Immunology and Biochemistry, having authored 92 papers that have together received 1.7k indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (9 papers), Machine Learning in Bioinformatics (6 papers), Antimicrobial Peptides and Activities (6 papers), Nanoparticle-Based Drug Delivery (6 papers), interferon and immune responses (5 papers), RNA and protein synthesis mechanisms (5 papers), Nanoplatforms for cancer theranostics (5 papers) and Genomics and Phylogenetic Studies (5 papers). The work is most often cited by research in Biomaterials (277 citations), Pharmaceutical Science (127 citations), Microbiology (103 citations), Immunology (343 citations) and Molecular Biology (828 citations). Mingyuan Li has collaborated with scholars based in China, United States and France. Frequent co-authors include Peng Yu, Shuangshuang Li, Chunyang Du, Hervé Galons, Hua Sun, Na Guo, Yuou Teng, Xin Meng, Shunfang Wang and Xiumin Yan. Their work appears in journals such as European Journal of Medicinal Chemistry, Biochemical and Biophysical Research Communications, International Journal of Food Science & Technology, Cancer Biotherapy and Radiopharmaceuticals and Archives of Virology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.